These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 12806958)

  • 1. [Second cancers associated with the cancer treatment and their possible control].
    Abe T; Nomura K
    Nihon Rinsho; 2003 Jun; 61(6):1045-51. PubMed ID: 12806958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myeloid leukemia after cytotoxic therapy and other hematotoxins.
    Larson RA
    J Toxicol Environ Health A; 2000 Nov; 61(5-6):381-6. PubMed ID: 11086943
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment-related leukaemia--a clinical and scientific challenge.
    Ng A; Taylor GM; Eden OB
    Cancer Treat Rev; 2000 Oct; 26(5):377-91. PubMed ID: 11006138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Secondary leukemias: their clinical features, incidence among populations at risk, mechanisms and new strategy for prediction].
    Abe T
    Gan To Kagaku Ryoho; 1999 Nov; 26(13):1999-2008. PubMed ID: 10584563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Leukemias induced by anticancer chemotherapies].
    Harousseau JL
    Bull Cancer; 1999 Nov; 86(11):929-38. PubMed ID: 10586109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is age an independent risk factor for chemically induced acute myelogenous leukemia in children?
    Pyatt DW; Aylward LL; Hays SM
    J Toxicol Environ Health B Crit Rev; 2007; 10(5):379-400. PubMed ID: 17687725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The risk of acute leukemia in patients treated for Hodgkin's disease is significantly higher aft [see bined modality programs than after chemotherapy alone and is correlated with the extent of radiotherapy and type and duration of chemotherapy: a case-control study.
    Brusamolino E; Anselmo AP; Klersy C; Santoro M; Orlandi E; Pagnucco G; Lunghi F; Maurizi-Enrici R; Baroni CD; Lazzarino M; Mandelli F; Bernasconi C
    Haematologica; 1998 Sep; 83(9):812-23. PubMed ID: 9825578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Therapy-related acute leukemia: study of 23 pacients].
    Motlló C; Sancho JM; García O; Granada I; Millá F; Ribera JM
    Med Clin (Barc); 2011 Oct; 137(10):449-52. PubMed ID: 21696789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do children have increased susceptibility for developing secondary acute myelogenous leukemia?
    Pyatt DW; Hays SM; Cushing CA
    Chem Biol Interact; 2005 May; 153-154():223-9. PubMed ID: 15878160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Chromosome translocations and leukemias induced by inhibitors of topoisomerase II anticarcinogenic drugs].
    Dassonneville L; Bailly C
    Bull Cancer; 1998 Mar; 85(3):254-61. PubMed ID: 9752316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapy-related leukemia and myelodysplastic syndrome: a large-scale Japanese study of clinical and cytogenetic features as well as prognostic factors.
    Takeyama K; Seto M; Uike N; Hamajima N; Ino T; Mikuni C; Kobayashi T; Maruta A; Muto Y; Maseki N; Sakamaki H; Saitoh H; Shimoyama M; Ueda R
    Int J Hematol; 2000 Feb; 71(2):144-52. PubMed ID: 10745624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapy-related leukemia associated with alkylating agents.
    Davies SM
    Med Pediatr Oncol; 2001 May; 36(5):536-40. PubMed ID: 11340608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemotherapy-induced secondary malignancies.
    Vega-Stromberg T
    J Infus Nurs; 2003; 26(6):353-61. PubMed ID: 14624175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Second tumors developing after therapy for malignant tumors in children].
    Kuleva SA; Kolygin BA
    Vopr Onkol; 2012; 58(5):606-15. PubMed ID: 23600276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Secondary acute myelogenous leukemia following treatment with oral etoposide.
    Katato K; Flaherty L; Varterasian M
    Am J Hematol; 1996 Sep; 53(1):54-5. PubMed ID: 8813107
    [No Abstract]   [Full Text] [Related]  

  • 16. Leukemogenic effect of chemotherapy in patients with breast carcinoma: is it a real concern?
    Ibrahim NK
    Cancer; 2004 Oct; 101(7):1479-81. PubMed ID: 15378475
    [No Abstract]   [Full Text] [Related]  

  • 17. Secondary leukemia after chemotherapy and/or radiotherapy for gynecologic neoplasia.
    Shimada T; Saito T; Okadome M; Shimamoto K; Ariyoshi K; Eto T; Tomita Y; Kodama K
    Int J Gynecol Cancer; 2014 Feb; 24(2):178-83. PubMed ID: 24407580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Therapy-related acute leukaemia and myelodysplastic syndrome].
    Díaz Beveridge R; Aparicio Urtasun J
    An Med Interna; 2003 May; 20(5):257-68. PubMed ID: 12831302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Function of topoisomerase II and the consequences of inhibition.
    Davies SM
    Med Pediatr Oncol Suppl; 1996; 1():12-9. PubMed ID: 8643041
    [No Abstract]   [Full Text] [Related]  

  • 20. Secondary acute lymphoblastic leukaemia following oxaliplatin for adjuvant chemotherapy in colon cancer.
    Merlin F; Prochilo T; Kildani B; Tucci A; Ferrari S; Rossi G; D'Adda P; Beretta GD
    Acta Oncol; 2008; 47(3):464-6. PubMed ID: 17851873
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.